This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $24,701.59, is for the supply of Olumiant 4 mg tablets to support federal healthcare programs. The contract has an ultimate completion date of October 25, 2024 and is a firm fixed-price delivery order. This award is not designated as a set-aside contract. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $2,911.17, is for the delivery of the prescription medication Olumiant 2 mg tablets. It is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of Olumiant 4 mg tablets. The $13,244.23 firm fixed-price delivery order has a completion date of July 8, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,292.85 firm fixed price contract is for the supply of the medication Olumiant 2 mg tablet. The delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is a Delivery Order valued at $4,043.48 issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of OLUMIANT 2 MG TABLET 30S, a pharmaceutical product, with a completion date of May 30, 2025. The contract is a Firm Fixed Price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,903.02, is a Firm Fixed Price Delivery Order for the supply of OLUMIANT 2 MG TABLET 30S. This award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $15,240.21, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OLUMIANT 4 MG TABLET 30S, a prescription medication. It is a firm-fixed-price delivery order contract with a completion date of December 16, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,601.71 firm fixed-price delivery order is for the supply of Olumiant 2 mg tablets, a medication used for the treatment of certain medical conditions. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award, valued at $1,085.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
This federal contract award, with ID SPE2DB22D2214|SPE2DB25FS4PN, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set aside, has a ceiling value of $41,565.55 and is a delivery order for the supply of the medication Olumiant 4 mg tablet in 30-count packaging. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...